| 5OX5: reference: Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials., Yeh TL, Leissing TM, Abboud MI, Thinnes CC, Atasoylu O, Holt-Martyn JP, Zhang D, Tumber A, Lippl K, Lohans CT, Leung IKH, Morcrette H, Clifton IJ, Claridge TDW, Kawamura A, Flashman E, Lu X, Ratcliffe PJ, Chowdhury R, Pugh CW, Schofield CJ, Chem Sci. 2017 Nov 1;8(11):7651-7668. doi: 10.1039/c7sc02103h. Epub 2017 Sep 11. PMID: 29435217 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).